Open main menu

Oldest pages

Showing below up to 100 results in range #301 to #400.

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

  1. Exponential survival curve‏‎ (20:01, 12 September 2019)
  2. Exposure, external or internal‏‎ (20:01, 12 September 2019)
  3. Exposure situation‏‎ (20:02, 12 September 2019)
  4. Habitual mouth breather‏‎ (12:42, 13 September 2019)
  5. Habitual nose breather‏‎ (12:42, 13 September 2019)
  6. Half-life, physical‏‎ (12:43, 13 September 2019)
  7. Hazard‏‎ (12:43, 13 September 2019)
  8. Health Surveillance‏‎ (12:43, 13 September 2019)
  9. Heliosphere‏‎ (12:44, 13 September 2019)
  10. Hierarchical tissues‏‎ (12:44, 13 September 2019)
  11. High level waste‏‎ (12:45, 13 September 2019)
  12. Hormones‏‎ (12:45, 13 September 2019)
  13. Hyperbaric oxygen‏‎ (12:46, 13 September 2019)
  14. Hypertrophic cardiomyopathy‏‎ (12:48, 13 September 2019)
  15. Hypoplasia‏‎ (12:48, 13 September 2019)
  16. Immune system‏‎ (12:49, 13 September 2019)
  17. Incident‏‎ (12:50, 13 September 2019)
  18. Inclusiveness‏‎ (12:50, 13 September 2019)
  19. Individual decontamination‏‎ (12:50, 13 September 2019)
  20. Individual monitoring‏‎ (12:51, 13 September 2019)
  21. Individual-related‏‎ (12:51, 13 September 2019)
  22. Inhalability‏‎ (12:53, 13 September 2019)
  23. Inner bremsstrahlung‏‎ (12:53, 13 September 2019)
  24. Institutional control‏‎ (12:54, 13 September 2019)
  25. Intermediate level waste‏‎ (12:54, 13 September 2019)
  26. Internal conversion electron‏‎ (12:56, 13 September 2019)
  27. Interphase death‏‎ (12:56, 13 September 2019)
  28. Intervention Level‏‎ (12:56, 13 September 2019)
  29. Interventional procedure‏‎ (12:57, 13 September 2019)
  30. Iso-effect plots‏‎ (12:58, 13 September 2019)
  31. Isomers‏‎ (12:58, 13 September 2019)
  32. Isotropic geometry‏‎ (12:58, 13 September 2019)
  33. Itinerant (radiation) worker‏‎ (12:59, 13 September 2019)
  34. Latent time/period or latency interval‏‎ (13:01, 13 September 2019)
  35. Limitation of dose‏‎ (13:01, 13 September 2019)
  36. Lineal energy‏‎ (13:02, 13 September 2019)
  37. Linear-non-threshold model‏‎ (13:03, 13 September 2019)
  38. Low level waste‏‎ (13:08, 13 September 2019)
  39. Lymphatic system‏‎ (13:08, 13 September 2019)
  40. Macrophage colony stimulating factor‏‎ (13:08, 13 September 2019)
  41. Magnetosphere‏‎ (13:09, 13 September 2019)
  42. Member of the public‏‎ (13:10, 13 September 2019)
  43. Mendelian diseases‏‎ (13:10, 13 September 2019)
  44. Mitigation‏‎ (13:10, 13 September 2019)
  45. Multistage tumorigenesis‏‎ (13:11, 13 September 2019)
  46. Myocardial perfusion‏‎ (13:12, 13 September 2019)
  47. Myocardial stress test‏‎ (13:13, 13 September 2019)
  48. Naturally occurring radioactive material‏‎ (13:14, 13 September 2019)
  49. Necrosis‏‎ (13:14, 13 September 2019)
  50. Neurological syndrome‏‎ (13:14, 13 September 2019)
  51. Neurovascular syndrome‏‎ (13:15, 13 September 2019)
  52. Non-sphericity parameter‏‎ (13:16, 13 September 2019)
  53. Nuclear track detectors‏‎ (13:17, 13 September 2019)
  54. Particle radiance‏‎ (13:28, 13 September 2019)
  55. Peak skin dose‏‎ (13:28, 13 September 2019)
  56. Pelagic‏‎ (13:29, 13 September 2019)
  57. Percutaneous coronary intervention‏‎ (13:29, 13 September 2019)
  58. Pericarditis‏‎ (13:29, 13 September 2019)
  59. Pharynx‏‎ (13:30, 13 September 2019)
  60. Planned exposure situation‏‎ (13:30, 13 September 2019)
  61. Platelet-derived growth factor‏‎ (13:30, 13 September 2019)
  62. Practical radiological protection culture‏‎ (13:32, 13 September 2019)
  63. Prevailing circumstances‏‎ (13:32, 13 September 2019)
  64. Principle of application of dose limits‏‎ (13:32, 13 September 2019)
  65. Principle of justification‏‎ (13:33, 13 September 2019)
  66. Principle of optimisation‏‎ (13:33, 13 September 2019)
  67. Procedural values‏‎ (13:34, 13 September 2019)
  68. Progenitor cell‏‎ (13:35, 13 September 2019)
  69. Projected dose‏‎ (13:36, 13 September 2019)
  70. Protection strategy‏‎ (13:37, 13 September 2019)
  71. Protective action‏‎ (13:37, 13 September 2019)
  72. Protective action guide‏‎ (13:38, 13 September 2019)
  73. Public exposure‏‎ (13:39, 13 September 2019)
  74. Radiation modifier‏‎ (13:41, 13 September 2019)
  75. Radiation safety officer‏‎ (13:42, 13 September 2019)
  76. Radiation worker‏‎ (13:44, 13 September 2019)
  77. Radioactive dispersion device‏‎ (13:44, 13 September 2019)
  78. Radioactive source‏‎ (13:45, 13 September 2019)
  79. Radioactive substance‏‎ (13:46, 13 September 2019)
  80. Radioactivity‏‎ (13:46, 13 September 2019)
  81. Radiofrequency ablation‏‎ (13:46, 13 September 2019)
  82. Radiographer‏‎ (13:48, 13 September 2019)
  83. Radiological protection principles‏‎ (13:49, 13 September 2019)
  84. Radionuclides of natural origin‏‎ (13:49, 13 September 2019)
  85. Radioresponsiveness‏‎ (13:49, 13 September 2019)
  86. Radiosensitiser‏‎ (13:50, 13 September 2019)
  87. Radiosensitivity, cellular‏‎ (13:50, 13 September 2019)
  88. Reasonableness‏‎ (13:50, 13 September 2019)
  89. Recovery‏‎ (13:51, 13 September 2019)
  90. Recovery responder‏‎ (13:51, 13 September 2019)
  91. Reference bioassay function‏‎ (13:51, 13 September 2019)
  92. Reference biokinetic model‏‎ (13:52, 13 September 2019)
  93. Reference level‏‎ (13:52, 13 September 2019)
  94. Rehabilitation of living conditions‏‎ (13:52, 13 September 2019)
  95. Relocation‏‎ (13:53, 13 September 2019)
  96. Remedial action‏‎ (13:53, 13 September 2019)
  97. Remediation‏‎ (13:53, 13 September 2019)
  98. Repopulation‏‎ (13:54, 13 September 2019)
  99. Representative organism (non-human biota)‏‎ (13:54, 13 September 2019)
  100. Representative person‏‎ (13:54, 13 September 2019)

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)